Labshake search
Citations for Leinco Technologies :
1 - 6 of 6 citations for PD L1 Cynomolgus HEK293 His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... and goat anti-human PD-L1 (1:50, Leinco Technologies, B560) at 4°C overnight and washed in PBS+0.1% Tween 20 for 5 min three times ...
-
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsivenessbioRxiv - Immunology 2023Quote: ... checkpoint blockade was performed by intraperitoneal injection of 200 ug anti-mouse PD-L1 (clone 10F.9G2, Leinco Technologies) or isotype control anti-rat IgG2gb ...
-
bioRxiv - Cancer Biology 2020Quote: ... or with 100 μg/mouse anti-mouse-Pd-1 (Leinco Technologies, P372) one and six days post tumor injection ...
-
bioRxiv - Immunology 2021Quote: ... mice were administered by IP injection either PBS vehicle or αPD-L1 (Leinco Technologies, Inc. Clone 10F.9G2) at a dose of 200 µg/mouse in a volume of 100µL ...
-
bioRxiv - Immunology 2022Quote: ... ICI was given by intraperitoneal injection with 200 μg anti PD-1 (clone RMP1-14, Leinco Technologies) and 100 μg anti CTLA-4 (clone 9D9 ...
-
bioRxiv - Immunology 2023Quote: ... they were treated with anti-PD-1 anti-CTLA-4 antibodies (clones RMP1-14 and 9H10, respectively, from Leinco Technologies Inc., Fenton, MO, USA): 200 µg ab/injection ...